Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, United States.
Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, United States.
Biochem Pharmacol. 2019 Oct;168:384-391. doi: 10.1016/j.bcp.2019.07.026. Epub 2019 Aug 2.
Drug uptake transporters are membrane proteins responsible for the trans-membrane transport of endo- and xenobiotics, including numerous drugs. They are important for the uptake of drugs into target tissues or into organs for metabolism and excretion. Many drug uptake transporters have a broad spectrum of structural-independent substrates, which make them vulnerable to drug-drug interactions. Recent studies have shown more and more complex pharmacokinetics involving transporters, and regulatory agencies now require studies to be performed to measure the involvement of transporters in drug development. A better understanding of the factors affecting the expression of transporters is needed. Despite many efforts devoted to the functional characterization of different drug uptake transporters, transporter in vitro to in vivo extrapolations are far from predicting the behavior under physiological conditions. There is an increasing number of uptake transporters demonstrated to form protein-protein interactions or to oligomerize. This raises the possibility that these interactions between or among transporters could help explaining the gap between in vitro and in vivo measurement of drug transporters. In this review, we summarized protein-protein interactions of drug uptake transporters that are important for pharmacokinetics, especially those in the liver and the kidneys.
药物摄取转运体是负责内源性和外源性物质(包括许多药物)跨膜转运的膜蛋白。它们对于将药物摄取到靶组织或代谢和排泄的器官中非常重要。许多药物摄取转运体具有广泛的结构非依赖性底物,这使它们容易受到药物-药物相互作用的影响。最近的研究表明,涉及转运体的药代动力学越来越复杂,监管机构现在要求进行研究以测量转运体在药物开发中的参与度。需要更好地了解影响转运体表达的因素。尽管人们为功能表征不同的药物摄取转运体做出了许多努力,但从体外到体内的转运体外推远不能预测生理条件下的行为。越来越多的摄取转运体被证明可以形成蛋白-蛋白相互作用或寡聚化。这提出了一个可能性,即这些转运体之间或转运体之间的相互作用可以帮助解释药物转运体在体外和体内测量之间的差距。在这篇综述中,我们总结了对药代动力学很重要的药物摄取转运体的蛋白-蛋白相互作用,特别是在肝脏和肾脏中的相互作用。